Skip to content

What is Synalgo for?

4 min read

The name 'Synalgo' can be confusing as it refers to two distinct medications with very different compositions and availability. To understand what is Synalgo for, it is essential to identify whether it is the discontinued opioid combination known as Synalgos-DC or the NSAID flurbiprofen, still available in some regions.

Quick Summary

This article explains the two different drugs known by the name 'Synalgo' or 'Synalgos-DC.' It outlines the composition, intended uses, risks, and current status of each, highlighting the critical differences in their pharmacology and legal standing.

Key Points

  • Synalgo is not a single drug: The name refers to two distinct medications—the discontinued opioid combination Synalgos-DC and the NSAID Synalgo (flurbiprofen) available internationally.

  • Synalgos-DC was an opioid: This combination of dihydrocodeine, aspirin, and caffeine was used for severe pain but is now discontinued in the US due to risks of addiction, respiratory depression, and overdose.

  • Synalgo (flurbiprofen) is an NSAID: It is used for inflammatory conditions like arthritis, muscle aches, and dental pain, but is not available in the US under this brand.

  • Both medications have serious risks: Synalgos-DC carried risks of addiction and respiratory depression, while flurbiprofen can cause gastrointestinal bleeding and increase heart attack/stroke risk, especially with long-term use.

  • Safer alternatives are available: For effective and safer pain relief, options like acetaminophen, non-opioid NSAIDs (ibuprofen, naproxen), and topical treatments can be used instead.

  • Consult a healthcare provider: It is crucial to consult a doctor to identify the right pain management strategy, especially given the confusion and risks associated with these drugs.

In This Article

Understanding the Confusion: Synalgo vs. Synalgos-DC

Many online searches for “What is Synalgo for?” lead to conflicting information because the name applies to two separate drug products. One is an opioid-combination medication, Synalgos-DC, that has been discontinued in the United States, while the other, Synalgo (flurbiprofen), is a nonsteroidal anti-inflammatory drug (NSAID) available in certain parts of the world. The differences in their active ingredients, uses, and risks are significant, and understanding them is vital for safe and effective pain management.

Synalgos-DC: The Discontinued Opioid-Combination

Synalgos-DC was a potent prescription pain medication used to treat moderate to moderately severe pain when non-opioid treatments were insufficient. It contained a powerful combination of three active ingredients:

  • Dihydrocodeine bitartrate: An opioid analgesic that binds to opioid receptors in the brain to decrease the sensation of pain. As a Schedule III controlled substance, it carried a significant risk of addiction, abuse, and misuse.
  • Aspirin: A nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, inflammation, and fever.
  • Caffeine: A central nervous system stimulant often included in pain medications to enhance the effects of other pain relievers.

Discontinuation and Major Risks

Synalgos-DC was discontinued and is no longer available in the United States, primarily due to the severe risks associated with its opioid and aspirin components. The potential for addiction, abuse, and life-threatening respiratory depression from dihydrocodeine was a major concern. Additionally, the aspirin component posed risks of serious gastrointestinal bleeding, ulcers, and a rare but dangerous condition called Reye's syndrome in children.

Synalgo (Flurbiprofen): The NSAID

In contrast to Synalgos-DC, the medication known as Synalgo in some countries, such as Pakistan, is an NSAID that contains a single active ingredient: flurbiprofen. It works by inhibiting the production of prostaglandins, which are chemicals in the body responsible for pain and inflammation.

Therapeutic Uses of Synalgo (Flurbiprofen)

Synalgo containing flurbiprofen is used to treat a variety of painful inflammatory conditions. These include:

  • Rheumatoid arthritis
  • Osteoarthritis
  • Dental pain
  • Menstrual cramps (dysmenorrhea)
  • Musculoskeletal pain and stiffness

Important Safety Considerations

Like all NSAIDs, flurbiprofen carries important warnings and should be used under a doctor's supervision. Key safety concerns include the potential for:

  • Gastrointestinal issues, such as stomach pain, nausea, and an increased risk of ulcers or bleeding.
  • Cardiovascular risks, including an increased risk of heart attack or stroke, especially with long-term use.
  • Fluid retention, which can be problematic for patients with congestive heart failure or hypertension.
  • Effects on the kidneys and liver with prolonged use.

Alternative Pain Management Options

For those who previously used Synalgos-DC or are seeking alternatives to NSAIDs like Synalgo, several safer options are available depending on the type and severity of pain. A healthcare provider can help determine the most appropriate choice.

Non-Opioid Alternatives:

  • Acetaminophen (Tylenol): An over-the-counter pain reliever and fever reducer that is a good first-line option for many types of pain.
  • Other NSAIDs: Readily available over-the-counter NSAIDs like ibuprofen (Advil, Motrin) and naproxen (Aleve) can be effective for pain and inflammation.
  • Topical Therapies: Gels or patches containing NSAIDs like diclofenac (Voltaren) or lidocaine can provide localized pain relief with less systemic absorption.
  • Non-Pharmacological Approaches: Non-drug options such as physical therapy, massage, acupuncture, and exercise can help manage chronic pain.

Prescription Alternatives (non-opioid):

  • Gabapentin: An anticonvulsant that can be used to treat nerve-related pain.
  • Tramadol: A centrally-acting opioid that carries less risk than some stronger opioids but still has a potential for abuse and dependency.

Synalgos-DC vs. Synalgo (Flurbiprofen) Comparison

Feature Synalgos-DC Synalgo (Flurbiprofen)
Active Ingredients Dihydrocodeine, Aspirin, Caffeine Flurbiprofen
Drug Class Narcotic analgesic combination (Opioid) Nonsteroidal anti-inflammatory drug (NSAID)
Availability in the US Discontinued Not available under this brand name
Controlled Substance Status Yes (Schedule III) No
Primary Use Moderate to moderately severe pain Pain and inflammation from arthritis, muscle aches, etc.
Major Risks Addiction, abuse, respiratory depression, GI bleeding, Reye's syndrome GI issues (ulcers, bleeding), cardiovascular events, renal issues

Conclusion

In summary, the medication referred to as Synalgo is actually two different drugs. In the United States, the name is associated with Synalgos-DC, a discontinued opioid combination medication with significant risks of addiction and overdose. However, in some other regions, Synalgo is an NSAID containing flurbiprofen, used for inflammatory pain conditions like arthritis. Due to the potent nature of both medications, neither should be used without a clear diagnosis and guidance from a healthcare professional. For pain management, safer non-opioid alternatives like acetaminophen, ibuprofen, or topical diclofenac are often recommended, particularly since Synalgos-DC is no longer on the US market. Always consult a doctor or pharmacist to discuss your specific medical history and appropriate pain relief strategies.

This article is for informational purposes only and does not constitute medical advice. For a list of FDA-approved alternatives and drug safety information, please consult the FDA's website.

Frequently Asked Questions

No, they are different drugs. Synalgos-DC was a discontinued opioid combination sold in the US, while Synalgo is an NSAID containing flurbiprofen, available in other countries.

No, Synalgos-DC was discontinued and is no longer available in the United States due to the high risks associated with its opioid component.

Flurbiprofen, the active ingredient in Synalgo tablets available in some regions, is an NSAID used to treat pain, stiffness, and swelling from conditions like arthritis, dental pain, and menstrual cramps.

The main risks of Synalgos-DC included a high potential for addiction and misuse due to the opioid content, as well as life-threatening respiratory depression, and severe GI issues from aspirin.

Yes, common risks include gastrointestinal issues like ulcers and bleeding. Long-term use can also increase the risk of heart attack, stroke, and negatively impact kidney and liver function.

Safer alternatives for pain relief include over-the-counter options like acetaminophen, ibuprofen, and naproxen. For chronic pain, non-pharmacological methods like physical therapy are also recommended.

The specific reasons for its market withdrawal are not publicly detailed, but the discontinuation is linked to the significant risks of addiction, abuse, and misuse associated with its opioid component, dihydrocodeine.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.